Multiple pathogens and prostate cancer

Table 10 Polyoma BKV, JCV prostate cancer

Study	Country	Method	Prostate cancer	Prostate non cancer controls	P value
Monini 1995 BKV [132]	Italy	PCR	4/7 57%	11/19 58%	0.986 ns Benign > cancer
Zambrano 2002 BKV [133]	US	PCR	2/8 25%	1/11 9%	0.427 ns
Zambrano 2002 JCV [133]	US	PCR	3/8 38%	4/11 36%	0.973 ns
Bergh 2007 JCV [97]	Sweden	PCR	3/159 2%	6/159 4%	0.324 ns Benign > cancer
Lau 2007 BKV [134]	US	ISH	2/30 7%	4/30 13%	0.481 ns Benign > cancer
Das 2008 BKV [135]	US	ISH	11/14 79%	4/15 27%	0.090 ns
Russo 2008 BKV [136]	Italy	IHC	20/26 77%	0/12 0%	0.004 s
Delbue 2013 BKV [137]	Italy	PCR	18/56 32%	15/68 22%	0.318 ns
Delbue 2013 JCV [137]	Italy	PCR	16/56 28%	16/68 24%	0.624 ns
Taghavi 2015 BKV [138]	Iran	PCR	17/60 28%	9/60 15%	0.154 ns
Gorish 2019 BKV [139]	Sudan	Immunofluoresence PCR	17/55 30% 16/17 94%	4/55 7% 2/4 50%	0.009 s 0.493 ns

IHC, immunohistochemistry; ISH, in situ hybridisation; s, significant; ns, non significant

ISSN: 1750-9378